Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?

W. A. Gattis, R. L. Larsen, V. Hasselblad, Bradley A Bart, C. M. O'Connor

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science